► Home ﹥News > 2017

2017/4/1

MPN Asia - Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia (ET) and Polycythemia vera (PV): Results after a Median 7-year Follow-up of a Phase 2 Study - Dr. Verstovsek


MPN Asia

The 2nd Annual International Symposium on Myeloproliferative Neoplasms

Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia (ET) and Polycythemia vera (PV): Results after a Median 7-year Follow-up of a Phase 2 Study

By Dr. Verstovsek






Copyright © 2008 PharmaEssentia Corporation All Rights Reserved.